Patents
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
11/1999
11/30/1999US5993788 Polysaccharide alkyl ether. protecting skin and hair against damaging effects of ultraviolet radiation.
11/30/1999US5993490 Composition for the oxidation dyeing of keratin fibers containing a cationic direct dye and dyeing process using this composition
11/26/1999CA2272838A1 Oxydation dye composition for keratin fibers and dyeing process using said composition
11/25/1999WO1999060127A2 Il-17 homologous polypeptides and therapeutic uses thereof
11/25/1999WO1999059972A1 Carboxy substituted carboxamide derivatives as tachykinin receptor antagonists
11/25/1999WO1999059598A1 Use of tricyclic antidepressants for local analgesia
11/25/1999WO1999059587A1 Anti-viral compounds
11/25/1999WO1999059564A1 Pharmaceutical composition comprising d-chiro-inositol for improving insulin sensitivity and glucose metabolism
11/25/1999WO1999048507A3 Steroidal saponins for treating alzheimer's disease
11/25/1999WO1999043344A3 Matrix protein compositions for wound healing
11/25/1999WO1998041226A9 Pharmaceutical combined preparations containing erythropoietin and iron preparations
11/25/1999WO1998018500A8 Improvements in or relating to diagnostic/therapeutic agents
11/25/1999CA2333310A1 Use of tricyclic antidepressants for local analgesia
11/25/1999CA2332444A1 Pharmaceutical composition comprising d-chiro-inositol for improving insulin sensitivity and glucose metabolism
11/25/1999CA2332403A1 Anti-viral compounds
11/25/1999CA2328496A1 Il-17 homologous polypeptides and therapeutic uses thereof
11/24/1999EP0958307A1 O-sulfated bacterial polysaccharides
11/24/1999EP0958289A1 Amino acid ester containing azole antifungals
11/24/1999EP0957898A1 Personal wash liquid composition comprising low viscosity oils pre-thickened by non-antifoaming hydrophobic polymers
11/24/1999EP0957897A1 Antiperspirant or deodorant compositions
11/24/1999EP0957895A1 Shaving composition and method for preventing pseudofolliculitis barbae
11/24/1999EP0957894A1 Hair coloring compositions
11/24/1999EP0550703B1 Plant-based medicament for enhancing and controlling the tone of smooth-muscle organs
11/24/1999CN1236366A Amino acid ester containing azole antifungals
11/24/1999CN1236318A Method for treating bronchitis with uridine triphosphates and related compounds
11/23/1999US5990329 Retinoids
11/23/1999US5989531 Antiperspirant formulation for porous applicator
11/23/1999CA1340825C Hyaluronic acid fraction for use as a drug delivery system for medicaments
11/18/1999WO1999058145A2 Immunomodulators for vaccines
11/18/1999WO1999058123A2 Novel fatty acid analogues for the treatment of primary and secondary restenosis
11/18/1999WO1999058122A1 Novel fatty analogues for the treatment of diabetes
11/18/1999WO1999058121A1 Novel fatty analogues for the treatment of obesity, hypertension and fatty liver
11/18/1999WO1999058120A1 USE OF NON-β-OXIDIZABLE FATTY ACID ANALOGUES FOR TREATMENT OF SYNDROME-X CONDITIONS
11/18/1999WO1999058099A2 Method for permanently shaping keratin fibres, and agents
11/18/1999WO1999041416A3 Compositions comprising viruses and methods for concentrating virus preparations
11/18/1999CA2384892A1 Method for permanently shaping keratin fibres, and agents
11/18/1999CA2331832A1 E.coli heat-labile enterotoxin subunit b (etxb) as an immunomodulator
11/17/1999EP0957087A2 Enzyme inhibitors
11/17/1999EP0956862A1 Methods of increasing lean tissue mass using ob protein compositions
11/17/1999EP0956854A1 Pharmaceutical composition comprising coenzyme q 10
11/17/1999EP0956851A1 Use of nanotopes in cosmetic products
11/17/1999EP0956013A1 Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid
11/17/1999CN1235594A Methods and compositions for lipidization of hydrophilic molecules
11/17/1999CN1235551A Pharmaceutical composition for diabetes
11/17/1999CN1235015A Use of nanodispersions in cosmetic end formulations
11/16/1999US5985851 Use of hyaluronic acid or its derivatives in peritoneal dialysis and formulations thereof
11/16/1999US5985850 Comprising a therapeutically effective amount of an agent to treat a disease or condition involving underperfused tissue and pathological tissue in humans and a form of hyaluronic acid as transport agent
11/16/1999US5985839 Treating cancer, psoriasis, acne
11/16/1999CA2064815C Therapeutic heterocyclic compounds
11/16/1999CA2037900C Pokeweed antiviral protein - monoclonal antibody conjugates
11/11/1999WO1999057127A1 2'-deoxy hygromycin derivatives
11/11/1999WO1999057125A2 Hygromycin a derivatives
11/11/1999WO1999057113A1 Heterocyclic derivatives which inhibit factor xa
11/11/1999WO1999056754A1 COMPOSITIONS CONTAINING AN α1,2-FUCOSE LINKAGE AND USES THEREOF
11/11/1999WO1999056540A1 Retarding formulations of active substances used for plant protection
11/11/1999WO1999046240A3 Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors
11/11/1999CA2331042A1 Heterocyclic derivatives which inhibit factor xa
11/10/1999EP0955049A2 6 Beta-Hydroxy - 6 alpha, 17 alpha - dimethylpregn - 4 ene - 3,20 - dione, as an inhibitor of smooth muscle proliferation
11/10/1999EP0531447B1 Compositions and methods for modulating rna activity through modification of the 5' cap structure of rna
11/10/1999CN1234742A Improvements in or relating to diagnostic/therapeutic agents and improvement relating to same
11/10/1999CN1234736A Preparation for transport of active substance across barriers
11/09/1999US5981693 Process for removing bile salts from a patient and alkylated compositions therefor
11/09/1999US5981589 Copolymer-1 improvements in compositions of copolymers
11/09/1999US5981512 Means for treating radiation injuries
11/09/1999US5980915 Administering an antiprotozoa agent
11/09/1999US5980871 Sunscreen compositions
11/04/1999WO1999055676A1 3-(amino- or aminoalkyl)pyridinone derivatives and their use for the treatment of hiv related diseases
11/04/1999WO1999055349A1 Substance mixture for topical application comprising olive oil and honey
11/04/1999CA2330304A1 3-(amino- or aminoalkyl)pyridinone derivatives and their use for the treatment of hiv related diseases
11/04/1999CA2329778A1 Improvements in or relating to diagnostic/therapeutic agents
11/04/1999CA2329301A1 Substance mixture for topical application comprising olive oil and honey
11/03/1999EP0953334A2 Composition for dying keratinous fibres with a direct cationic dye and a substantive polymer
11/03/1999EP0952839A2 Green ointment
11/03/1999EP0952836A1 New use
11/03/1999EP0952811A1 Hair coloring compositions
11/03/1999EP0952809A1 Foaming personal cleansing product
11/03/1999CN1233955A Pharmaceutical prepn. comprising eicosapentaenoic acid and/or stearidonic acid
11/03/1999CN1233466A Cationic direct dye and direct-dyeing polymer composition used for dyeing keratin-fiber
11/02/1999US5977136 Tetrahydroquinolines as NMDA antagonists
11/02/1999US5977105 Compounds
11/02/1999US5977037 Personal hygiene; mixture of anionic and amphoteric surfactant
11/02/1999US5976507 At least one of the active ingredients is a calcium salt or fluoride salt contained in a capsule being formed from a plasticized alkyl cellulose polymer.
10/1999
10/28/1999WO1999054333A1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
10/28/1999WO1999054329A1 Novel 2-heterocyclically substituted dihydropyrimidines
10/28/1999WO1999053901A1 Pharmaceutical aerosol formulation
10/28/1999WO1999053893A1 Desensitizing dentifrice containing potassium and tin salts
10/28/1999WO1999004773A9 Method for inhibiting bone resorption
10/28/1999CA2329175A1 Improvements in or relating to contrast agents
10/28/1999CA2328882A1 Pharmaceutical aerosol formulation
10/28/1999CA2328876A1 Novel 2-heterocyclically substituted dihydropyrimidines
10/27/1999EP0951273A2 Antiperspirant composition in stick form
10/27/1999EP0951270A1 Hair coloring compositions
10/27/1999CN1232701A Process for preparing herbal compositions for treatment of bronchitis and respiratory disorders with anticancer properties
10/26/1999US5972896 Antiangiogenic peptides and methods for inhibiting angiogenesis
10/26/1999US5972891 A mixture comprising an active nonapeptide or decapeptide and a biodegradable polymer having a terminal carboxyl group, showing constant release of the peptide over a long time
10/26/1999US5972598 Methods for preventing multidrug resistance in cancer cells
10/26/1999US5972319 Antiperspirant stick with improved characteristics
10/21/1999WO1999052910A1 Bicyclic hydroxamic acid derivatives
10/21/1999WO1999052907A1 Azabicyclic 5ht1 receptor ligands
10/21/1999WO1999052531A1 New treatments for nervous disorders